Evidence map›Paper›PMID 31913011›Full record

ArticleACS combinatorial science2020

Homogeneous and Functional Group Tolerant Ring-Closing Metathesis for DNA-Encoded Chemical Libraries.

Olivier B C Monty, Pranavanand Nyshadham, Kurt M Bohren, Murugesan Palaniappan, Martin M Matzuk, Damian W Young, Nicholas Simmons

Abstract read
In one paragraph

Article in ACS combinatorial science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. FSOACS medicinal chemistry letters · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 MProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Olivier B C MontyCenter for Drug Discovery and Department of Pathology and Immunology , Baylor College of Medicine , One Baylor Plaza , Houston , Texas 77030 , United States.
Pranavanand NyshadhamCenter for Drug Discovery and Department of Pathology and Immunology , Baylor College of Medicine , One Baylor Plaza , Houston , Texas 77030 , United States.
Kurt M BohrenCenter for Drug Discovery and Department of Pathology and Immunology , Baylor College of Medicine , One Baylor Plaza , Houston , Texas 77030 , United States.
Murugesan PalaniappanCenter for Drug Discovery and Department of Pathology and Immunology , Baylor College of Medicine , One Baylor Plaza , Houston , Texas 77030 , United States.
Martin M MatzukCenter for Drug Discovery and Department of Pathology and Immunology , Baylor College of Medicine , One Baylor Plaza , Houston , Texas 77030 , United States.
Damian W YoungCenter for Drug Discovery and Department of Pathology and Immunology , Baylor College of Medicine , One Baylor Plaza , Houston , Texas 77030 , United States.ORCID 0000-0002-1595-9658
Nicholas SimmonsCenter for Drug Discovery and Department of Pathology and Immunology , Baylor College of Medicine , One Baylor Plaza , Houston , Texas 77030 , United States.ORCID 0000-0003-0766-5382

Funding

Targeting sperm-specific proteins during meiosis and sperm morphogenesisP01HD087157 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MATZUK, MARTIN M. · 2017 to 2021
$6.2M
FOXA1 inhibitors to overcome endocrine resistance in ER+ breast cancerP20CA221729 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MATZUK, MARTIN M. · 2018 to 2021
$1.0M
NCI NIH HHS P20 CA221729NICHD NIH HHS P01 HD087157
6 · The paper itself

Abstract

Reaction heterogeneity, poor pH control, and catalyst decomposition in the ring-closing metathesis (RCM) of DNA-chemical conjugates lead to poor yields of the cyclized products. Herein we address these issues with a RCM reaction system that includes a novel aqueous solvent combination to enable reaction homogeneity, an acidic buffer system which masks traditionally problematic functional groups, and a decomposition-resistant catalyst which maximizes conversion to the cyclized product. Additionally, we provide a systematic study of the substrate scope of the on-DNA RCM reaction, a demonstration of its applicability to a single-substrate DNA-encoded chemical library that includes sequencing analysis, and the first successful stapling of an unprotected on-DNA [i, i+4] peptide.

Indexed as

BuffersCatalysisCyclizationDNAGene LibraryPeptidesSmall Molecule LibrariesBuffersDNAPeptidesSmall Molecule LibrariesDNA-encoded chemistryDNA-encoded librariesfunctional group-tolerant ring-closing metathesishomogeneous ring-closing metathesisstapled peptides

Identifiers

PMID31913011
PMCPMC7014401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.